Zentalis Pharmaceuticals gives stock options and restricted stock units to new employee

From GlobeNewswire: 2025-03-03 17:00:00

Zentalis Pharmaceuticals granted 50,000 stock options and 25,000 restricted stock units to a newly hired employee on March 3, 2025. The options and units were granted under the 2022 Employment Inducement Incentive Award Plan. The stock options have an exercise price of $1.92 per share and will vest over four years, while the restricted stock units will also vest over four years. Both are subject to the employee’s continued service to Zentalis. Zentalis is a clinical-stage biopharmaceutical company developing a WEE1 inhibitor for ovarian cancer and other tumor types, with operations in San Diego.



Read more at GlobeNewswire: Zentalis Pharmaceuticals Announces Inducement Grants Under